Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study reveals how antipsychotics pass to baby during pregnancy and breastfeeding

NCT ID NCT05766007

First seen Feb 19, 2026 · Last updated May 24, 2026 · Updated 17 times

Summary

This study followed 168 pregnant or breastfeeding women with serious mental health conditions like schizophrenia or mania who were already taking long-acting injectable antipsychotics. Researchers measured drug levels in the mother's blood, breastmilk, and the baby's blood to understand how much of the medication reaches the infant. The goal is to help doctors make better decisions about using these drugs during pregnancy and breastfeeding.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREGNANCY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Federal Medical Centre

    Makurdi, Benue State, Nigeria

  • Federal Neuropsychiatric Hospital

    Kaduna, Kaduna State, Nigeria

  • Federal Neuropsychiatric Hospital

    Yaba, Lagos, Nigeria

  • Neuropsychiatric Hospital

    Abeokuta, Ogun State, Nigeria

  • Neuropsychiatric Specialist Hospital

    Akure, Ondo State, Nigeria

  • Obafemi Awolowo University Teaching Hospital

    Ile-Ife, Osun State, Nigeria

Conditions

Explore the condition pages connected to this study.